Brazil: Food, Drugs, Healthcare, Life Sciences

Subscribe
Welcome to the Mondaq Food, Drugs, Healthcare, Life Sciences homepage, here you will find thought leadership articles, podcasts, videos and webinars providing insights covering topics such as Food and Drugs Law, Healthcare, Life Sciences, Biotechnology and Nanotechnology.
Article
Biocon Enters Ten-Year Pertuzumab Supply Contract In Brazil
Biocon Limited has partnered with Brazilian companies Bahiafarma and Bionovis to secure an exclusive ten-year supply contract for its pertuzumab biosimilar in Brazil's public healthcare market. The partnership aims to improve access to this HER2-positive breast cancer treatment while reducing costs and developing Brazil's domestic pharmaceutical manufacturing capabilities through phased localization.
Brazil Healthcare
GP
Goodwin Procter LLP
Article
Anvisa abrirá processo para regulamentar venda de medicamentos em plataformas
Brazil's health regulatory agency Anvisa has approved the opening of an administrative process to regulate the sale and delivery of medicines through digital marketplaces, aiming to update sanitary rules to reflect the reality of online pharmaceutical retail that has evolved far beyond the outdated 2009 regulations. The decision comes after Law 15.357/2026 authorized pharmacies to contract digital platforms for logistics and delivery services, yet significant legal uncertainties remain about compliance requ
Brazil Healthcare
LA
Licks Attorneys
See more

Food and Drugs Law

Article
Anvisa abrirá processo para regulamentar venda de medicamentos em plataformas
Brazil's health regulatory agency Anvisa has approved the opening of an administrative process to regulate the sale and delivery of medicines through digital marketplaces, aiming to update sanitary rules to reflect the reality of online pharmaceutical retail that has evolved far beyond the outdated 2009 regulations. The decision comes after Law 15.357/2026 authorized pharmacies to contract digital platforms for logistics and delivery services, yet significant legal uncertainties remain about compliance requ
Brazil Healthcare
LA
Licks Attorneys
Article
Reavaliação de agroquímicos e devido processo legal administrativo
A recent decision by Brazil's Federal Regional Court of the 1st Region confirms that the Ministry of Agriculture holds final authority over agrochemical use decisions following environmental assessments by Ibama. This ruling addresses regulatory inconsistencies in the re-evaluation process of active ingredients, particularly regarding imidacloprid, and establishes that uniform treatment must apply to both registered products and new registration requests.
Brazil Government
LA
Licks Attorneys
See more

Life Sciences, Biotechnology & Nanotechnology

Article
Biocon Enters Ten-Year Pertuzumab Supply Contract In Brazil
Biocon Limited has partnered with Brazilian companies Bahiafarma and Bionovis to secure an exclusive ten-year supply contract for its pertuzumab biosimilar in Brazil's public healthcare market. The partnership aims to improve access to this HER2-positive breast cancer treatment while reducing costs and developing Brazil's domestic pharmaceutical manufacturing capabilities through phased localization.
Brazil Healthcare
GP
Goodwin Procter LLP
Article
BRPTO Announces Collaborative Examination Program With INDECOPI
The Brazilian Patent and Trademark Office (BRPTO) and Peru's INDECOPI have launched a collaborative examination initiative for patent applications in pharmaceuticals, biotechnology, and natural products. This partnership, formalized through a 2025 Bilateral Cooperation Memorandum, will provide expedited technical examination for qualifying PCT applications that entered the national phase between October 2022 and July 2023.
Brazil IP
LA
Licks Attorneys
See more

Healthcare

Article
Biocon Enters Ten-Year Pertuzumab Supply Contract In Brazil
Biocon Limited has partnered with Brazilian companies Bahiafarma and Bionovis to secure an exclusive ten-year supply contract for its pertuzumab biosimilar in Brazil's public healthcare market. The partnership aims to improve access to this HER2-positive breast cancer treatment while reducing costs and developing Brazil's domestic pharmaceutical manufacturing capabilities through phased localization.
Brazil Healthcare
GP
Goodwin Procter LLP
See more